Related Experiment Videos
Prenatal treatment of congenital adrenal hyperplasia
1Division of Pediatric Endocrinology and Metabolism, North Shore University Hospital, Manhasset, New York, USA.
Insights
Prenatal intervention for congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH-21) can reduce genital ambiguity in affected females. While risks of treating unaffected pregnancies are considered small, long-term effects require further study.
Area of Science:
- Pediatric Endocrinology
- Genetics
- Reproductive Medicine
Background:
- Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH-21) is the leading cause of female pseudohermaphroditism.
- Prompt diagnosis is crucial to prevent life-threatening adrenal insufficiency in infants.
- Understanding CAH-21 is vital for evaluating prenatal intervention strategies.
Purpose of the Study:
- To review the benefits and risks associated with prenatal intervention for CAH-21.
- To assess the current understanding of CAH-21 management and its implications.
Main Methods:
- Review of relevant literature on CAH-21.
- Discussion of diagnostic methods including serum 17-hydroxyprogesterone, karyotype, and ultrasound.
- Consideration of postnatal treatment protocols and prenatal diagnostic/therapeutic approaches.
Main Results:
- Effective postnatal management allows affected individuals to thrive, with many women conceiving healthy children.
- Prenatal diagnosis using molecular genetic techniques is feasible.
- Prenatal treatment, when combined with diagnosis, is an option for at-risk pregnancies.
Conclusions:
- CAH-21 is a well-characterized condition.
- Prenatal therapy aims to mitigate genital ambiguity in affected females.
- Potential risks of treating unaffected pregnancies require long-term monitoring; careful medical supervision is essential for prenatal treatment.
Purpose:
The relevant aspects of congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH-21), the single most common cause of female pseudohermaphroditism, are reviewed to understand the benefits and risks of prenatal intervention. Timely diagnosis is important, since infants with this condition may suffer adrenal insufficiency which carries a high mortality rate.
Materials And Methods:
Infants suspected of having CAH-21 should undergo radioimmunoassay of serum 17-hydroxyprogesterone, karyotype and pelvic/abdominal ultrasound at a minimum. Treatment with glucocorticoid and mineralocorticoid supplements should be instituted immediately. Surgical correction of genitourinary tract anomalies should be performed by a pediatric urologist experienced in this area.
Results:
Proper postnatal medical and surgical management of CAH-21 will allow the patient to thrive. Many women with classic CAH-21 have now conceived and delivered healthy children. Prenatal diagnosis, now most often done by molecular genetic techniques, is feasible and often done in conjunction with prenatal treatment of the at risk mother.
Conclusions:
CAH-21 has been well characterized. The benefit of prenatal therapy is to ameliorate potentially genital ambiguity in affected female subjects. The risks of unnecessarily treating unaffected pregnancies, which now seem small, may not be fully elucidated for many years. Prenatal treatment must be done under careful, centralized and ideally long-term medical supervision.